Efficacy and safety of lamotrigine (LTG) as add-on therapy was assessed in a randomised double-blind placebo-controlled trial of this drug in 23 adult patients with refractory partial seizures. Fifteen patients showed an improvement on LTG treatment, with a greater than 50% decrease in total seizure
A randomized double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy
β Scribed by J.W.A.S. Sander; P.N. Patsalos; J.R. Oxley; M.J. Hamilton; W.C. Yuen
- Publisher
- Elsevier Science
- Year
- 1990
- Tongue
- English
- Weight
- 616 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0920-1211
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Safinamide is an Ξ±βaminoamide with both dopaminergic and nondopaminergic mechanisms of action evaluated as an addβon to dopamine agonist (DA) therapy in earlyβstage PD. In this 24βweek, doubleβblind study, patients with early PD receiving a stable dose of a single DA were randomized to
Pruritus is defined as the second order of nociception, the first being pain; thus, there is a rationale to study gabapentin, a drug that increases the threshold to experience nociception. The aim of this double-blind, randomized, placebo-controlled trial was to study the effect of gabapentin on the